Certified by Founder Lodge
SV Health Investors
United Kingdom - London, London
INVESTOR
1 Disclosed Funding Rounds $125,000,000
19 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
SV Health Investors is a specialist healthcare fund manager, investing across stages, geographic regions, and sectors, with expertise spanning biotechnology, dementia, healthcare growth, heal
Company | Date | Round | Raised |
---|---|---|---|
Miach Orthopaedics, Inc. | April, 04 ,2024 | Series B | $20,000,000 |
Nimbus Therapeutics | September, 13 ,2022 | Unknown | $125,000,000 |
Therini Bio, Inc. | April, 27 ,2023 | Series A | $36,000,000 |
Brixton Biosciences | May, 15 ,2024 | Series B | $33,000,000 |
Sitryx | September, 28 ,2023 | Unknown | $39,500,000 |
Spineology Inc. | August, 07 ,2024 | Unknown | $25,000,000 |
EyeBio | November, 15 ,2023 | Series A | $65,000,000 |
SpectraWAVE, Inc. | September, 12 ,2024 | Series B | $50,000,000 |
Harness Therapeutics | December, 01 ,2023 | Unknown | $5,067,000 |
LoQus23 Therapeutics Ltd | October, 02 ,2024 | Series A | $46,550,175 |
Miach Orthopaedics, Inc. | April, 04 ,2024 | Series B | $20,000,000 |
Enara Bio | October, 04 ,2024 | Series B | $32,500,000 |
Brixton Biosciences | May, 15 ,2024 | Series B | $33,000,000 |
TRexBio | November, 14 ,2024 | Series B | $84,000,000 |
Spineology Inc. | August, 07 ,2024 | Unknown | $25,000,000 |
SpectraWAVE, Inc. | September, 12 ,2024 | Series B | $50,000,000 |
LoQus23 Therapeutics Ltd | October, 02 ,2024 | Series A | $46,550,175 |
Enara Bio | October, 04 ,2024 | Series B | $32,500,000 |
TRexBio | November, 14 ,2024 | Series B | $84,000,000 |